FILTER BY:
Details
Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma
Address: 1 Gustave L. Levy Pl, New York, NY 10029, USA
Phone: 877-451-7009
Mesothelioma Type:
- Pleural: True
- Peritoneal: False
- Pericardial: False
- Tunica Vaginalis: False
Type: Epitheliod, Biphasic, Sarcomatoid
Condition: Malignant Pleural Mesothelioma
Description: This study will examine the safety and potential effectiveness of poly-ICLC directly injected into malignant pleural mesothelioma at the time of biopsy up to 21 days prior to the cancer being removed by the surgeon
Research Center: Icahn School of Medicine Mount Sinai
Treatment Interventions: BIOLOGICAL: Safety, BIOLOGICAL: Expansion Cohort
Potential Impact: Low
Clinical Trial Number: NCT04525859
Phase: Phase 1
Status: Recruiting
